Poster Walk : Clinical Research and Epidemiology

Date: Thursday 23 September 2021
Time: 14.40-16.00 CET

 

Leader: Su Lwin

Program

 

 

 

14:45

[Poster 039]

Glucagon-like peptide-1 analogues and sodium-glucose co-transporter-2 inhibitors do not increase risk of bullous pemphigoid

Outi Varpuluoma

 

14:52

[Poster 043]

Role of Prostaglandin E-major Urinary Metabolite Levels in Identifying The Phenotype of Pachydermoperiostosis

Mami Ishibashi

14:59

[Poster 051]

STAT3 nuclear translocation in circulating MAIT cells is a potential biomarker of clinical outcome to ustekinumab in psoriasis
Shane Solanky

15:06

[Poster 052]

Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two staged, adaptive placebo controlled trial (APRICOT)
Thomas Tull

15:13

[Poster 069]

Multi-omic analyses highlight key molecular pathways in dystrophic epidermolysis bullosa pruriginosa
Maria Papanikolaou

15:20

[Poster 044]

Safety and efficacy of anti-IL-17 (Secukinumab) for the treatment of pyoderma gangrenosum
Felix Lauffer

15:27

[Poster 061]

Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
Janin Edelkamp

15:34

[Poster 042]

Atopic dermatitis and the risk of eating disorders
Laura Huilaja